Used in the management of type 2 diabetes mellitus as an antihyperglycemic agent. It functions by enhancing the action of incretin hormones, which increase insulin release and reduce glucagon levels in a glucose-dependent manner. This helps lower both fasting and postprandial blood glucose levels. Typically administered orally once daily, it is often used as monotherapy or in combination with other antidiabetic agents such as metformin or insulin. Its glucose-lowering effect is associated with a low risk of hypoglycemia and does not typically cause weight gain, making it a favorable option in long-term diabetes care.